Evidence map›Paper›PMID 31893023›Full record

ArticleCell & bioscience2019

Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ.

Zhongli Geng, Wei Wang, Hui Chen, Jianya Mao, Zhenguo Li, Jing Zhou

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhongli Geng1Department of Surgery, Affiliated Hospital of Traditional Chinese, Medicine Xinjiang Medical University, 116 Huanghe Road, Urumchi, 830000 Xinjiang China.ORCID 0000-0002-6670-9763
Wei Wang1Department of Surgery, Affiliated Hospital of Traditional Chinese, Medicine Xinjiang Medical University, 116 Huanghe Road, Urumchi, 830000 Xinjiang China.
Hui Chen1Department of Surgery, Affiliated Hospital of Traditional Chinese, Medicine Xinjiang Medical University, 116 Huanghe Road, Urumchi, 830000 Xinjiang China.
Jianya Mao1Department of Surgery, Affiliated Hospital of Traditional Chinese, Medicine Xinjiang Medical University, 116 Huanghe Road, Urumchi, 830000 Xinjiang China.
Zhenguo LiDepartment of Head and Neck Surgery, Qitai County People's Hospital, Changji, Xinjiang China.
Jing Zhou1Department of Surgery, Affiliated Hospital of Traditional Chinese, Medicine Xinjiang Medical University, 116 Huanghe Road, Urumchi, 830000 Xinjiang China.
Xinjiang Medical University · CNQujiang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is a most common type of cancer in women. Circular RNAs (circRNAs) are involved in cancer development and progression, but their roles and regulatory mechanisms are unclear in breast cancer. Our previous study indicated that has_circ_0001667 (circ_0001667) was up-regulated in breast cancer from the array and might play an oncogenic role, however, the roles of circ_0001667 were not known. This study was aimed to investigate the role and the underlying molecular mechanism of circ_0001667 in breast cancer.

resultsThe real-time PCR result showed that circ_0001667 was overexpressed in breast cancer tissues or cell lines compared to the adjacent normal tissues or normal cells. There was a negative relationship between circ_0001667 levels and the life time of breast cancer patients. Meanwhile, the inhibition of circ_0001667 suppressed the proliferation and metastasis of human breast cancer cells. Further bioinformatical analysis indicated that circ_0001667 sponged miR-125a-5p to regulate TAZ expression by Targetscan and miRanda. Dual luciferase reporter assay and western blotting experiments revealed that circ_0001667 negatively regulated miR-125a-5p expression leading to promoting TAZ expression through Hippo signal pathway in breast cancer cells.

conclusionsThis study uncovered that circ_0001667 was a potential breast cancer prognostic marker, as well as a potential therapeutic target to inhibit breast cancer metastasis by circ_0001667/miR-125a-5p/TAZ axis.

Indexed as

Breast cancercirc_0001667Hippo pathwaymiR-125a-5pTAZ

Identifiers

PMID31893023
PMCPMC6937801
OpenAlexW2997017339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.